Search research articles
Contact Us
Filters
Showing results (111-120 of 177) with videos related to
Page
of 18
Sort By:
Cancer Medicine
|
July 31, 2025
Economic Benefits of Sponsored Clinical Trials in Cancer for the Colombian Healthcare System: A Real-World Evidence Approach
Leonardo Rojas, Natalia Sánchez, Jorge Ceballos, et al.
Cancer Chemotherapy and Pharmacology
|
February 25, 2014
A phase II study of capecitabine plus docetaxel in gemcitabine-pretreated metastatic pancreatic cancer patients: CapTere
Heloisa P Soares, Soley Bayraktar, Marcelo Blaya, et al.
Eclinicalmedicine
|
February 19, 2025
Evolving trends in lung cancer risk factors in the ten most populous countries: an analysis of data from the 2019 Global Burden of Disease Study
Chinmay T Jani, Samuel A Kareff, Dan Morgenstern-Kaplan, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 18, 2006
Efficacy and safety of oxaliplatin and docetaxel in patients with locally advanced and metastatic non-small-cell lung cancer (NSCLC)
Luis E Raez, Edgardo S Santos, Gilberto Lopes, et al.
Cancer Medicine
|
February 23, 2021
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
Jayson L Parker, Sebnem S Kuzulugil, Kirill Pereverzev, et al.
Breast (Edinburgh, Scotland)
|
November 26, 2025
Improving equitable access to comprehensive care for people with advanced breast cancer: a global expert review and call-to-action for 2025-2035 (Goal 9)
Alexandru Eniu, Runcie C W Chidebe, Peter Vuylsteke, et al.
JAMA Network Open
|
December 5, 2023
Time to Cancer Treatment and Chemotherapy Relative Dose Intensity for Patients With Breast Cancer Living With HIV
Daniel S O'Neil, Yehoda M Martei, Katherine D Crew, et al.
Cancer Treatment and Research Communications
|
April 30, 2026
The genomic, transcriptomic, and immunologic landscape of TEM8 (ANTXR1) in neuroendocrine neoplasms (NENs) including small-cell lung cancer (SCLC)
Samuel A Kareff, Harris Krause, Andrew Elliott, et al.
Lung Cancer (Amsterdam, Netherlands)
|
April 17, 2018
The burden of lung cancer in Latin-America and challenges in the access to genomic profiling, immunotherapy and targeted treatments
Luis E Raez, Andrés F Cardona, Edgardo S Santos, et al.
Journal of the National Cancer Institute
|
January 27, 2021
The Global Landscape of Treatment Standards for Breast Cancer
Dario Trapani, Jean Yves Douillard, Eric P Winer, et al.
Page
of 18
Search research articles
Search
Showing results (111-120 of 177) with videos related to
Sort By:
Page
of 18
Cancer Medicine
|
July 31, 2025
Economic Benefits of Sponsored Clinical Trials in Cancer for the Colombian Healthcare System: A Real-World Evidence Approach
Leonardo Rojas, Natalia Sánchez, Jorge Ceballos, et al.
Cancer Chemotherapy and Pharmacology
|
February 25, 2014
A phase II study of capecitabine plus docetaxel in gemcitabine-pretreated metastatic pancreatic cancer patients: CapTere
Heloisa P Soares, Soley Bayraktar, Marcelo Blaya, et al.
Eclinicalmedicine
|
February 19, 2025
Evolving trends in lung cancer risk factors in the ten most populous countries: an analysis of data from the 2019 Global Burden of Disease Study
Chinmay T Jani, Samuel A Kareff, Dan Morgenstern-Kaplan, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 18, 2006
Efficacy and safety of oxaliplatin and docetaxel in patients with locally advanced and metastatic non-small-cell lung cancer (NSCLC)
Luis E Raez, Edgardo S Santos, Gilberto Lopes, et al.
Cancer Medicine
|
February 23, 2021
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
Jayson L Parker, Sebnem S Kuzulugil, Kirill Pereverzev, et al.
Breast (Edinburgh, Scotland)
|
November 26, 2025
Improving equitable access to comprehensive care for people with advanced breast cancer: a global expert review and call-to-action for 2025-2035 (Goal 9)
Alexandru Eniu, Runcie C W Chidebe, Peter Vuylsteke, et al.
JAMA Network Open
|
December 5, 2023
Time to Cancer Treatment and Chemotherapy Relative Dose Intensity for Patients With Breast Cancer Living With HIV
Daniel S O'Neil, Yehoda M Martei, Katherine D Crew, et al.
Cancer Treatment and Research Communications
|
April 30, 2026
The genomic, transcriptomic, and immunologic landscape of TEM8 (ANTXR1) in neuroendocrine neoplasms (NENs) including small-cell lung cancer (SCLC)
Samuel A Kareff, Harris Krause, Andrew Elliott, et al.
Lung Cancer (Amsterdam, Netherlands)
|
April 17, 2018
The burden of lung cancer in Latin-America and challenges in the access to genomic profiling, immunotherapy and targeted treatments
Luis E Raez, Andrés F Cardona, Edgardo S Santos, et al.
Journal of the National Cancer Institute
|
January 27, 2021
The Global Landscape of Treatment Standards for Breast Cancer
Dario Trapani, Jean Yves Douillard, Eric P Winer, et al.
Page
of 18